Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2021

View Archived Issues

Bayer initiates phase II study of runcaciguat in nonproliferative diabetic retinopathy

Boehringer Ingelheim starts enrolling participants in phase I study of BI-1323495

VB-85247, a member of a novel class of macrocyclic STING agonists

Brain metastases of breast cancer depend on fatty acid synthesis

FDA clears IND for phase II study of MIT-001 as therapy of CCRT-induced oral mucositis in HNSCC

Enrollment begins in phase III study of futibatinib in CCA harboring FGFR2 gene rearrangements

First patient dosed in phase II AFFINITY basket study of atrasentan

Biotest adds additional patient group to ongoing phase III AdFIrst study of BT-524

Alkermes collaborates with MSD to evaluate nemvaleukin alfa in combination with Keytruda

Shionogi and Hsiri Therapeutics patent compounds for mycobacterial infections

X-Chem discloses new HAOX1 inhibitors

Terns identifies thyroid hormone receptor beta agonists

Vincere Biosciences presents new USP30 inhibitors

First cohort fully enrolled in WWRD Study of AVM-0703

Cell Biotech divulges vector constructs for colon cancer

Trodelvy granted expanded approval by FDA for metastatic TNBC

Phenex Pharmaceuticals develops novel class of heme-displacing IDO-1 inhibitors

Subcutaneous injection of Tysabri approved in Europe for relapsing-remitting MS

Enrollment ongoing in phase II study of IC-14 chimeric antibody in patients with COVID-19

Calico and AbbVie initiate first-in-human study of ABBV-CLS-484

RMC-5552 enters phase I development for relapsed/refractory solid tumors

SMN gene therapy can result in too much of a good thing

Patient recruitment ongoing in phase III study of Tookad VTP in upper tract urothelial carcinoma

Stearoyl-CoA-desaturase inhibitor YTX-7739 shows efficacy in glioblastoma mouse models

NIH initiates study to assess allergic reactions to Moderna and Pfizer-BioNTech COVID-19 vaccines

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...